[ Price : $8.95]
Former CDRH branch chief Morris Waxler tells CBS News LASIK eye surgery should be pulled from the market due to complications.[ Price : $8.95]
FDAs Endocrinologic and Metabolic Drugs Advisory Committee votes to not recommend approval of Eli Lilly and Boehringer Ingelheims ...[ Price : $8.95]
FDA says the Botanical Safety Consortium has been formally convened under a memorandum of understanding between FDA and two resear...[ Price : $8.95]
FDA approves BeiGenes Brukinsa capsules to treat some adults with mantle cell lymphoma.[ Price : $8.95]
FDA releases an FDA-483 with four inspection observations on an inspection at Isorx Corp.[ Price : $8.95]
FDA clears a NantHealth 510(k) for its Omics Core, a whole exome tumor-normal in vitro diagnostic that measures overall tumor muta...[ Price : $8.95]
FDA grants X4 Pharmaceuticals a breakthrough therapy designation for mavorixafor for the treatment of adult patients with WHIM (Wa...[ Price : $8.95]
FDA places a clinical hold on a Marker Therapeutics planned Phase 2 study of its MultiTAA T-cell therapy in post-allogeneic hemato...